Obeticholic acid is the generic ingredient in one branded drug marketed by Intercept Pharms Inc and is included in one NDA. There are ten patents protecting this compound.
Drug patent litigation for OBETICHOLIC ACID.
This ingredient has one hundred and eighteen patent family members in thirty-eight countries.
One supplier is listed for this compound. There is one tentative approval for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
